Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections

OBJECTIVES: Teicoplanin, an antibiotic, has poor clinical efficacy when using the current drug label’s recommended regimen, which is approved by the China Food and Drug Administration. This study explores the appropriate loading and maintenance doses of teicoplanin and evaluates the therapeutic targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lijuan, Gao, Yanqiu, Cao, Wei, Liu, Jia, Guan, Hongya, Zhang, Hua, Shi, Yun, Lv, Wenying, Cheng, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759846/
https://www.ncbi.nlm.nih.gov/pubmed/29379306
http://dx.doi.org/10.2147/IDR.S146961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759846/
https://www.ncbi.nlm.nih.gov/pubmed/29379306
http://dx.doi.org/10.2147/IDR.S146961

Ejemplares similares